Mediastinal node removal versus sparing nodes for early lung nodule
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two surgical approaches for people with a single small, noncancer-looking lung nodule (a GGN) that is diagnosed as very early lung cancer. It aims to see whether removing mediastinal lymph nodes—or leaving them alone—can lead to better outcomes with less harm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your thin-slice CT scan shows one ground-glass nodule (GGN) with a ratio (C/T) of 0.5 or less
- There is no evidence of lung cancer spread to nearby lymph nodes on imaging
- You have very early lung cancer (stage IA NSCLC) diagnosed before surgery or during surgery
- You have not had other cancers in the past 5 years and have not had lung surgery before
- You have not had chemo, radiation, or other cancer treatments before your planned surgery
- You do not have serious lung scarring or severe lung disease (like interstitial pneumonitis, pulmonary fibrosis, or severe emphysema) and you do not have an active infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This study compares two surgical approaches for removing lymph nodes in the chest after you've completed chemotherapy and immunotherapy for non-small cell lung cancer. The goal is to determine which approach works best while keeping you as safe as possible.
This trial looks at complications from removing lymph nodes during surgery for non-small cell lung cancer. It may help doctors understand how to make surgery safer.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This study looks at whether removing lymph nodes in different ways improves outcomes for people with a specific kind of lung nodule seen on CT (a “ground-glass” spot with a mostly solid part). You may qualify if you are planning lung surgery and the CT measurements match the study’s exact thresholds.
This study looks at whether different lymph node removal methods during lung surgery change outcomes for certain abnormal lung spots. It focuses on ground-glass nodules that stay the same after treatment-free observation and have a mostly solid portion on CT.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.